Incremental diagnostic value of targeted biopsy using mpMRI-TRUS fusion versus 14-fragments prostatic biopsy: a prospective controlled study
Sign Up to like & getrecommendations! Published in 2017 at "European Radiology"
DOI: 10.1007/s00330-017-4939-0
Abstract: ObjectivesTo compare the incremental diagnostic value of targeted biopsy using real-time multiparametric magnetic resonance imaging and transrectal ultrasound (mpMRI-TRUS) fusion to conventional 14-cores biopsy.Patients and MethodsUni-institutional, institutional review board (IRB) approved prospective blinded study comparing… read more here.
Keywords: trus fusion; biopsy; trus; mpmri trus ... See more keywords
Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2016.07.007
Abstract: &NA; The detection rate for clinically significant prostate cancer (PCa) of transperineal (TP) versus transrectal (TR) multiparametric (mp) magnetic resonance imaging (MRI)/transrectal ultrasound‐guided (TRUS) fusion targeted biopsy has been prospectively evaluated in 200 men submitted… read more here.
Keywords: prostate; targeted biopsy; trus fusion; clinically significant ... See more keywords
The role of reference pathology to assess MRI-TRUS fusion prostate biopsies in a tertiary referral center.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.6_suppl.32
Abstract: 32Background: Risk stratification for patients diagnosed with prostate cancer (PCa) through MR-TRUS fusion biopsy still relies on Gleason (GL) grading of the biopsy specimens. GL grading of the same sample can differ between pathologists. In… read more here.
Keywords: trus fusion; biopsy; reference pathology; pathology ... See more keywords